|
Artificial Intelligence Model for Prediction of Optimal Peptide Binding to Specific MHC Alleles
This technology is an artificial intelligence (AI) software platform that predicts which tumor-derived peptides are most likely to bind to a patient’s specific major histocompatibility complex (MHC) alleles. By combining tumor sequencing data with patient-specific MHC profiles, the model helps identify neoantigens for personalized cancer vaccine...
Published: 7/22/2026
|
Updated: 7/22/2026
|
Inventor(s): Michael Kuhns, Ryan Sprissler, Ryan Gutenkunst, Heng Wu
Keywords(s):
Category(s): Technology Classifications > Healthcare Portfolios > Oncology, Technology Classifications > Life Sciences > Therapeutics, Technology Classifications > Life Sciences > Vaccines, Technology Classifications > Software & Information Technology > Health IT
|
